Switzerland - Import of Extracts of Glands for Therapeutic Use
Since 2014, Switzerland Import of Extracts of Glands for Therapeutic Use jumped by 5.5% year on year. In 2019, the country was number 13 among other countries in Import of Extracts of Glands for Therapeutic Use with $4,814,053. Switzerland is overtaken by United States, which was number 12 with $5,299,376.99 and is followed by Russia with $4,225,343.7. Italy topped the ranking with $26,618,146.87 in 2019, that is -3.3% compared to 2018. South Korea, Japan and Denmark respectively ranked number 2, 3 and 4 in this ranking. Egypt witnessed the best average annual growth at +196% per year, while Namibia witnessed the worst performance at -71.2% per year.
Date | US Dollars |
---|---|
2019 | 4,814,053.00 |
2018 | 4,815,741.50 |
2017 | 4,792,016.00 |
2016 | 5,417,999.00 |
2015 | 2,769,092.00 |
Download all data from 1988 to 2019
How does Switzerland rank in Import of Extracts of Glands for Therapeutic Use?
# | 128 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Italy
|
26,618,146.87 | 2019 | -3.3 % | +7.0 % | View data | |
2 |
#2
South Korea
|
13,760,816.36 | 2019 | +7.0 % | +17.3 % | View data | |
12 |
#12
United States
|
5,299,376.99 | 2019 | +7.4 % | -15.3 % | View data | |
13 |
#13
Switzerland
|
4,814,053.00 | 2019 | -0.0 % | +5.5 % | View data | |
14 |
#14
Russia
|
4,225,343.70 | 2019 | +5.3 % | +23.7 % | View data |